Date: 28.10.2015
A twist on a revolutionary gene-editing technique may make it possible to modify plant genomes while sidestepping national biosafety regulations, South Korean researchers say.
Plant scientists have been quick to experiment with the popular CRISPR/Cas9 technique, which uses an enzyme called Cas9, guided by two RNA strands, to precisely cut segments of DNA in a genome. By disabling specific genes in wheat and rice, for example, researchers hope to make disease-resistant strains of the crops.
But the process can introduce bits of foreign DNA into plant genomes. And some jurisdictions, such as the European Union, could decide to classify such plants as genetically modified organisms (GMOs) — making their acceptance by regulatory bodies contentious, says geneticist Jin-Soo Kim of Seoul National University.
Kim and his team tweaked the technique so that it can delete specific plant genes without introducing foreign DNA, creating plants that he and his colleagues think “might be exempt from current GMO regulations”.
“In terms of science, our approach is just another improvement in the field of genome editing. However, in terms of regulations and public acceptance, our method could be path-breaking,” says Kim.
It is unclear what stance regulatory authorities will take on CRISPR-edited plants. The European Commission is currently debating regulations to take into account the latest techniques, and it is conceivable that it will still classify plants as GMOs even if they lack foreign DNA.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Animal Biotechnology - Animals, animal biotech
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
Mashed up purple marine bacteria makes an excellent eco-friendly fertilizer
New nanoparticles boost immune system in mice to fight melanoma and breast cancer